CIK: 1397266 - Address: C/O Atara Biotherapeutics, Inc., 2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA 91320
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/22/24 16:31
3/20/24
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADM.d1,25520.9206019D
3/22/24 16:31
3/20/24
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-2,64844.140-60-7619D
3/11/24 12:54
3/7/24
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS-62050.880-12-4515D
7/15/22 16:30
7/13/22
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADM.d81.45068313D
7/15/22 16:30
7/13/22
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-11920.960-6-3113D
3/8/22 12:25
3/4/22
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADM.d30340.37084823D
11/5/21 16:28
11/4/21
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagFust Matthew KCADS-26019.500-13-3032D
11/3/21 16:55
11/1/21
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADM.d171.910925013D
11/3/21 16:55
11/1/21
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-22825.500-9-4213D
9/9/21 17:00
9/8/21
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADM.d121.91069313D
9/9/21 17:00
9/8/21
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-15425.500-6-3313D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact